ACE2 and pancreatic adenocarcinoma: Notably, colon adenocarcinoma (COAD), kidney renal papillary cell carcinoma (KIRP), pancreatic adenocarcinoma (PAAD), rectum adenocarcinoma (READ) and stomach adenocarcinoma (STAD) presented with increased ACE2 expression (Figure 1A).